<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BIIB</title>
    <link />
    <description>Headlines for Biogen Idec</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>DaVita and Myriad Join Forces - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101851/davita-and-myriad-join-forces.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 18 Jun 2013 22:25:01 GMT</pubDate>
    </item>
    <item>
      <title>Biogen Idec Inc (BIIB): Today's Featured Drugs Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11954233/1/biogen-idec-inc-biib-todays-featured-drugs-winner.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 18 Jun 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Perrigo in Expansion Mode - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101789/perrigo-in-expansion-mode.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 18 Jun 2013 16:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Biogen's New Multiple Sclerosis Drug to Test Recent Stock Gains</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130618-000224&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Tue, 18 Jun 2013 09:14:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Explores Sale Options - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101712/elan-explores-sale-options.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Jun 2013 21:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Amgen Xgeva Label Expanded - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101708/amgen-xgeva-label-expanded.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Jun 2013 20:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Why Coronado Biosciences Is Poised to Keep Plunging</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/why-coronado-biosciences-is-poised-to-keep-plungin/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 11:22:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotechs Lose Ground As Achillion Takes a Dive</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/15/biotechs-lose-ground-as-achillion-takes-a-dive/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 15 Jun 2013 13:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Is In Play</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1503482-elan-is-in-play.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 15 Jun 2013 05:06:54 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging Data on Novartis' Gilenya  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101620/encouraging-data-on-novartis-gilenya.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 14 Jun 2013 21:25:01 GMT</pubDate>
    </item>
    <item>
      <title>Supreme Court Lets the Gene Out of the Bottle</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/14/supreme-court-lets-the-gene-out-of-the-bottle/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Jun 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Bull Of The Day: Biogen</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1503232-bull-of-the-day-biogen.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 17:29:55 GMT</pubDate>
    </item>
    <item>
      <title>Apremilast Data Presented by Celgene - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101578/apremilast-data-presented-by-celgene.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 14 Jun 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>The Biggest Companies That Don't Pay Dividends - But May Be About To</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1502802-the-biggest-companies-that-don-t-pay-dividends-but-may-be-about-to.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Jun 2013 14:33:03 GMT</pubDate>
    </item>
    <item>
      <title>Buzz on the Street: Investors Prepare for Fed Announcement After Volatile Week</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/business-news/editors-pick/articles/buzz-on-the-street253a-investors-prepare/6/14/2013/id/50335.aspx</link>
      <author>Minyanville</author>
      <pubDate>Fri, 14 Jun 2013 14:33:00 GMT</pubDate>
    </item>
    <item>
      <title>Buzz on the Street: Investors Prepare for Fed Announcement After Volatile Week</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/buzz-on-the-street-investors-prepare-for-fed-announcement-after-volatile-week-cm253321.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 14 Jun 2013 14:33:00 GMT</pubDate>
    </item>
    <item>
      <title>Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101540/amgens-oncology-drug-meets-primary-endpoint.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 13 Jun 2013 23:00:01 GMT</pubDate>
    </item>
    <item>
      <title>CELG Presents Positive Long-term Data - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101509/celg-presents-positive-long-term-data.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 13 Jun 2013 20:45:01 GMT</pubDate>
    </item>
    <item>
      <title>Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/06/13/merrill-lynch-top-biotechnology-stocks-to-buy-for-big-gains/.aspx</link>
      <author>247wallst</author>
      <pubDate>Thu, 13 Jun 2013 08:15:59 GMT</pubDate>
    </item>
    <item>
      <title>Novartis: 5 Year Revenue Outlook</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1499052-novartis-5-year-revenue-outlook.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 13 Jun 2013 05:34:41 GMT</pubDate>
    </item>
  </channel>
</rss>
